Trial intelligence / Profile preview

Influenza vaccination in preschool children attending day care

ACTRN12610000319077Phase 4Completed

Sponsor
Australian Research Council
Start
Jun 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised trial of Vaxigrip Junior in influenza (2 arms), sponsored by Australian Research Council. Primary endpoints: Social, economic, and health impact of influenza prevention, Vaccine efficacy and effectiveness against laboratory-proven influenza and influenza-like illness and 1 more. Started Jun 2006; status: completed.

02

Drugs

Vaxigrip Junior
03

Conditions

influenza

Beyond the preview

Go deeper on ACTRN12610000319077.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000319077.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call